Atención médica de calidadDescubra por qué Mayo Clinic es el mejor lugar para atenderse. Pide una cita.
The research activities of Joel M. Reid, Ph.D., are focused on characterization of the preclinical pharmacology, clinical pharmacokinetics and metabolism of anti-cancer agents. Dr. Reid's research team has designed and conducted preclinical and clinical pharmacology studies and published peer-reviewed findings for more than 75 anti-cancer agents.
The majority of Dr. Reid's research is conducted with oncology drugs in the late stages of preclinical development or early stages of clinical development; these phases of development are where pharmacokinetic and metabolism data are critical to understanding outcomes of early clinical trials. This research emphasizes the development of new methodologies to expedite preclinical and clinical evaluations, the use of LC-MS/MS methodologies for trace analysis and structure elucidation of drugs and metabolites, and the implementation of pharmacogenetic studies in clinical protocols to include development and validation of assays for genetic variants of proteins associated with drug response.
Future research directions include development of highly sensitive LC-MS/MS-based approaches to characterize drug metabolite pharmacokinetics and application of systems biology methodologies to characterize drug pharmacokinetics at the molecular level.
Recent projects in Dr. Reid's laboratory include:
Dr. Reid's studies are pivotal in assuring safe and optimal use of pharmacological agents during subsequent clinical development and patient use.
Infórmate sobre los ensayos clínicos que abordan preguntas científicas específicas sobre la salud humana y las enfermedades.
Explora todos los estudios de investigación en Mayo Clinic.
Ver las conclusiones revisadas por colegas que publiqué como resultado de mi investigación.